Sign in
Taking people in United StatesNo phase

Bed Scale Device Tested with Weight Loss Program for Wheelchair Users

Tests a bed scale and weight loss program in adults with obesity who use wheelchairs.

Key facts

Who runs it
Jonathan Pearlman
Where
Pittsburgh, United StatesSee the site
Trial code
Registry title
Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Complete a Weight Loss Program, Half Get Scales at Baseline, Half at Month 6 Those Who Receive the Bed Scales at Baseline Are Expected to Have Increased Weight Loss
Status
Recruiting
People taking part
20 people, planned
Started
16 Feb 2026
Expected to end
31 Jul 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • The Fast In-Bed Tracking System (FIT) Weight Scale
  • Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention
Record updated
29 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who use a wheelchair, are overweight or obese, want to lose weight and get into bed most nights. They join a weight loss program, half with bed scales from the start.

Age
18 years or older
Sex
All sexes can join
Disease stage
Diagnosed as overweight or obese, with a BMI of about 25 to 40 (for spinal cord injury about 22 to 40; the study team decides case by case)
Earlier treatment
No weight loss medicine or medicine that affects appetite, and no weight loss surgery in the last 2 years

Main reasons for not taking part

  • Weight loss medicine or appetite-affecting medicine, or weight loss surgery in the last 2 years
  • Eating disorder in the last 2 years
  • Pregnant or planning pregnancy in the next 12 months
  • 4 or more alcoholic drinks a day
  • Cognitive conditions that limit decision making

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Age18 +
  • Live within approximately 75 miles of Pittsburgh
  • Uses a wheelchair as primary means of locomotion
  • Currently transfers in and out of bed every night (or most nights)
  • Has been diagnosed as obese or overweight
  • Are interested in losing weight
  • BMI in the range of approximately 25 to 40; BMI range will be determined from published evidence for the primary diagnosis of the participant. For example, spinal cord injury /quadriplegic BMI range of approximately 22 to 40; for amputees it will be based on location and level of amputation, or if no diagnosis specific evidence exists, a BMI of approximately 25 to 40 will be used as a general guideline
  • Own a smart phone, and have reliable internet and wifi connection
  • Are comfortable using exercise equipment like resistance bands or hand pedal exercisers
  • Are able and willing to engage in exercise of moderate intensity
  • Weight in bed including sleep partner is an estimated combined weight of 600 pounds or less
  • Does not have a regular way to weigh themselves, such as a roll-on scale in the home or gym, or have regular access to a device to weigh themselves regularly and are willing to avoid weighing themselves during the trial
  • Indication that the participant has autonomy in decision-making as determined by the "Everyday Autonomy Self-Determination Scale."
  • Indication that their current bedroom setup is compatible with the FIT bed scales as determined by the "Bed Determination Survey."; Due to the medical complexity of this population, inclusion of this study based on BMI, in-bed transfer frequency, or geographic location will be at the discretion of the expert members of our study team and will be considered on a case-by-case basis

Who cannot take part

  • Currently taking weight loss medication, medications that affect appetite, or have had weight loss surgery in the last 2 years
  • Indication that their current bedroom setup is not compatible with the FIT bed scales as determined by the "Bed Determination Survey."; Due to the medical complexity of this population, exclusion from this study based on BMI, geographic location, and what is considered a "medication that affects appetite" will be at the discretion of the expert members of our study team and will be considered on a case-by-case basis
  • BMI outside of the desired range as based on condition and as determined by the study team
  • History disordered eating in the last 2 years, such as Anorexia Nervosa, Bulimia Nervosa or Binge Eating Disorder
  • Have any cognitive conditions that limit decision making or self-governing
  • Extended vacations or absences planned in the next year (more that 2 - 4 weeks) or plans to move approximately 75 miles or greater from the Pittsburgh region
  • Currently pregnant or intend to become pregnant in the next 12 months
  • Regularly have 4 or more alcoholic drinks a day
  • Indication that the participant does not have autonomy in decision-making as determined by the "Everyday Autonomy Self-Determination Scale."

Where in United States

  • University of Pittsburgh, Bakery Square, Department of Rehabilitation Science and TechnologyPittsburgh, United StatesContact: Daniel Rusnak, MSTaking people

About the trial

What the trial wants to find out

This project will complete the final design and development steps to commercialize the Fast In-Bed Tracking (FIT) Platform, which is an e-Health and wellness Internet of Things (IoT) monitoring system that can be integrated into a user's bed and provide person-centered, real-world outcomes to support health and wellness. The technical feasibility of FIT was proven over the past several years and has demonstrated the platform can support the treatment of several chronic conditions across different populations, including obesity, congestive heart failure, and pressure injuries. The project goals will be to (1) complete design refinements for FIT and (2) demonstrate the platform's efficacy to support weight loss goals of wheelchair users. Wheelchair users are twice as likely as the general population to be overweight or obese and excess weight not only exacerbates mobility and participation limitations but increases risk for secondary health problems. Evidence reveals that frequent weight monitoring is a key driver for weight management, which puts wheelchair users at a significant disadvantage, because they have no convenient way to measure their body weight. As a recent example, lack of participant's ability to self-weigh was a noted limitation to a weight loss program for wheelchair users, known as the Group Lifestyle Balance weight loss program Adapted for Individuals with Impaired Mobility (GLB-AIM). FIT solves this challenge by passively monitoring a user's weight when they get on and off their bed. The investigators lab and community-based feasibility trials demonstrated that FIT successfully tracks weight for individuals and couples sharing a bed and that users find FIT highly usable. This proposed project will allow the investigators to complete the design refinements participants recommended during our community-based feasibility trial and subsequently examine the efficacy of FIT in supporting the weight-loss goals of community-dwelling wheelchair users through a randomized controlled trial using the GLB-AIM.

The 2 groups in the trial

  • GLB-AIMExisting treatment, for comparison

    All participants in the control group will receive the Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention. The investigators anticipate a total of 46 participants will be randomized to the control group. THE GLB-AIM is a 12-month intervention with a total of 23 sessions: 13 weekly core sessions to start the program, followed by 3 bi-weekly support sessions, and reducing to 1 monthly support session for the final 7 months. Control participants will be asked to download the My Net Diary app onto their personal phone and to log daily food intake and exercise using the app for the first 13 weeks of the GLB-AIM program. All subjects in the study will be enrolled in the GLB-AIM intervention; the only difference between the experimental and control group is that the control group will not receive the Fast In Bed Tracking System (FIT) scale until month 6 and will not have the ability to monitor their weight during core intervention sessions.

    Treatment: Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention

  • GLB-AIM + FIT Weight ScalesTreatment being tested

    All participants in the experimental group will receive the Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention and will be asked to download the My Net Diary app. The investigators anticipate a total of 46 participants will be randomized to the experimental group. Participants who are randomized to the FIT Weight Scale Group will have the FIT scale set up in-home during the baseline visit by research team members. Intervention participants will be oriented to their scale if randomized into the FIT scale group. Participants will be asked to enter their weight daily into the My Net Diary app.

    Treatment: The Fast In-Bed Tracking System (FIT) Weight Scale and Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Fast In-Bed Tracking (FIT) System Lifestyle Intervention
Plain-language title
Bed Scale Device Tested with Weight Loss Program for Wheelchair UsersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
29 July 2026